- Home
- KZR vs BSX Comparison
KZR vs BSX Comparison
Compare KZR & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZR
- BSX
- Stock Information
- Founded
- KZR 2015
- BSX 1979
- Country
- KZR United States
- BSX United States
- Employees
- KZR N/A
- BSX N/A
- Industry
- KZR Biotechnology: Pharmaceutical Preparations
- BSX Medical/Dental Instruments
- Sector
- KZR Health Care
- BSX Health Care
- Exchange
- KZR Nasdaq
- BSX Nasdaq
- Market Cap
- KZR N/A
- BSX 138.4B
- IPO Year
- KZR 2018
- BSX 1992
- Fundamental
- Price
- KZR $4.52
- BSX $103.19
- Analyst Decision
- KZR Hold
- BSX Strong Buy
- Analyst Count
- KZR 2
- BSX 22
- Target Price
- KZR $9.00
- BSX $112.86
- AVG Volume (30 Days)
- KZR 42.6K
- BSX 7.4M
- Earning Date
- KZR 08-12-2025
- BSX 07-23-2025
- Dividend Yield
- KZR N/A
- BSX N/A
- EPS Growth
- KZR N/A
- BSX 15.23
- EPS
- KZR N/A
- BSX 1.37
- Revenue
- KZR N/A
- BSX $17,554,000,000.00
- Revenue This Year
- KZR N/A
- BSX $17.50
- Revenue Next Year
- KZR N/A
- BSX $10.75
- P/E Ratio
- KZR N/A
- BSX $75.30
- Revenue Growth
- KZR N/A
- BSX 19.36
- 52 Week Low
- KZR $3.62
- BSX $71.88
- 52 Week High
- KZR $9.18
- BSX $107.53
- Technical
- Relative Strength Index (RSI)
- KZR 51.73
- BSX 49.67
- Support Level
- KZR $4.45
- BSX $101.56
- Resistance Level
- KZR $4.81
- BSX $104.41
- Average True Range (ATR)
- KZR 0.29
- BSX 1.83
- MACD
- KZR 0.02
- BSX -0.11
- Stochastic Oscillator
- KZR 60.81
- BSX 34.54
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.